Simon Donkor

ORCID: 0000-0002-6334-5984
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Immunodeficiency and Autoimmune Disorders
  • Pneumonia and Respiratory Infections
  • Diagnosis and treatment of tuberculosis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • vaccines and immunoinformatics approaches
  • Immune responses and vaccinations
  • Infectious Diseases and Tuberculosis
  • Child Nutrition and Water Access
  • Iron Metabolism and Disorders
  • Respiratory viral infections research
  • Hemoglobinopathies and Related Disorders
  • Poxvirus research and outbreaks
  • Viral Infections and Immunology Research
  • Viral gastroenteritis research and epidemiology
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Blood groups and transfusion
  • Genetics, Bioinformatics, and Biomedical Research
  • Biochemical and Molecular Research
  • HIV Research and Treatment
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Hematological disorders and diagnostics
  • Global Maternal and Child Health

MRC Unit the Gambia
2015-2024

University of Education, Winneba
2020

Massachusetts Department of Environmental Protection
2016

Harvard Global Health Institute
2016

Public Health Department
2016

The University of Melbourne
2016

Medical Research Council
2003-2015

National Tuberculosis Institute
2006

London School of Hygiene & Tropical Medicine
2003

Sara Suliman Ethan Thompson Jayne S. Sutherland January Weiner Martin O. C. Ota and 95 more Steven G. Smith Adam Penn‐Nicholson Bonnie Thiel Mzwandile Erasmus Jeroen Maertzdorf Fergal J. Duffy Philip C. Hill E. Jane Hughes Kim Stanley Katrina Downing Michelle Fisher Joe Valvo Shreemanta K. Parida Gian van der Spuy Gerard Tromp Ifedayo Adetifa Simon Donkor Rawleigh Howe Harriet Mayanja‐Kizza W. Henry Boom Hazel M. Dockrell Tom H. M. Ottenhoff Mark Hatherill Alan Aderem Willem A. Hanekom Thomas J. Scriba Stefan H. E. Kaufmann Daniel E. Zak Gerhard Walzl Gerhard Walzl Gillian F. Black Gian van der Spuy Kim Stanley Magdalena Kriel Nelita du Plessis Nonhlanhla Nene Teri Roberts Léanie Kleynhans Andrea Gutschmidt Bronwyn Smith Nonhlanhla Nene André G. Loxton Novel N. Chegou Gerard Tromp David L. Tabb Tom H. M. Ottenhoff Michèl R. Klein Mariëlle C. Haks Kees L. M. C. Franken Annemieke Geluk Krista E. van Meijgaarden Simone A. Joosten W. Henry Boom Bonnie Thiel Harriet Mayanja‐Kizza Moses Joloba Sarah Zalwango Mary Nsereko Brenda Okwera Hussein Kisingo Stefan H. E. Kaufmann Shreemanta K. Parida Robert Golinski Jeroen Maertzdorf January Weiner Mark Z. Jacobson Hazel M. Dockrell Steven G. Smith Patricia Gorak‐Stolinska Yun‐Gyoung Hur Maeve K. Lalor Ji‐Sook Lee Amelia C. Crampin Neil French Bagrey Ngwira Anne Ben‐Smith Kate E. Watkins Lyn Ambrose Felanji Simukonda Hazzie Mvula Femia Chilongo Jacky Saul Keith Branson Sara Suliman Thomas J. Scriba Hassan Mahomed E. Jane Hughes Nicole Bilek Mzwandile Erasmus Onke Xasa Ashley Veldsman Katrina Downing Michelle Fisher Adam Penn‐Nicholson Humphrey Mulenga

Rationale: Contacts of patients with tuberculosis (TB) constitute an important target population for preventive measures because they are at high risk infection Mycobacterium and progression to disease.Objectives: We investigated biosignatures predictive ability incident TB.Methods: In a case–control study nested within the Grand Challenges 6-74 longitudinal HIV-negative African cohort exposed household contacts, we employed RNA sequencing, PCR, pair ratio algorithm in training/test set...

10.1164/rccm.201711-2340oc article EN American Journal of Respiratory and Critical Care Medicine 2018-04-06

Microneedle patches (MNPs) have been ranked as the highest global priority innovation for overcoming immunisation barriers in low-income and middle-income countries. This trial aimed to provide first data on tolerability, safety, immunogenicity of a measles rubella vaccine (MRV)-MNP children.

10.1016/s0140-6736(24)00532-4 article EN cc-by The Lancet 2024-04-29

Background Host-related and environment-related factors have been shown to play a role in the development of tuberculosis (TB), but few studies were carried out identify their respective roles resource-poor countries.

10.1093/ije/dyi100 article EN International Journal of Epidemiology 2005-05-24

Background Very little longitudinal information is available regarding the performance of T cell-based tests for Mycobacterium tuberculosis infection. To address this deficiency, we conducted a assessment enzyme-linked immunosorbent spot test (ELISPOT) in comparison to standard tuberculin skin (TST). Methods and Findings In (TB) contacts repeated ELISPOT 3 mo (n = 341) 18 210) after recruitment TSTs at 130). We evaluated factors association with conversion reversion investigated suspected...

10.1371/journal.pmed.0040192 article EN cc-by PLoS Medicine 2007-06-05
January Weiner Jeroen Maertzdorf Jayne S. Sutherland Fergal J. Duffy Ethan Thompson and 95 more Sara Suliman Gayle K. McEwen Bonnie Thiel Shreemanta K. Parida Joanna Żyła Willem A. Hanekom Robert P. Mohney W. Henry Boom Harriet Mayanja‐Kizza Rawleigh Howe Hazel M. Dockrell Tom H. M. Ottenhoff Thomas J. Scriba Daniel E. Zak Gerhard Walzl Stefan H. E. Kaufmann Almaz Abebe Bernd Abel Richard A. Adegbola Ifedayo Adetifa Lyn Ambrose Peter Andersen Martín Antonio Abraham Aseffa Debbie van Baarle Lew Barker Yonas Bekele Nicole Bilek Gillian F. Black Mark Bowmaker Keith Branson Michael J. Brennan Novel N. Chegou Femia Chilongo William Kwong Chung Tumani Corrah Ameilia C. Crampin Mark Doherty Gregory Dolganov Simon Donkor Katrina Downing Michelle Fisher Kees L. M. C. Franken Neil French Larry Geiter Annemieke Geluk Robert Golinski Patricia Gorak‐Stolinska Mariëlle C. Haks Philip C. Hill Jane Hughes Yun‐Gyoung Hur Rachel Iwnetu Mark Z. Jacobson Moses Joloba Simone A. Joosten Benjamin M. Kagina Desta Kassa Hussein Kisingo Michèl R. Klein Magdalena Kriel Maeve K. Lalor Ji‐Sook Lee André G. Loxton Hassan Mahomed Krista E. van Meijgaarden Tsehayenesh Mesele Frank Miedema Adane Mihret Humphrey Mulenga Stefanie Müller Hazzie Mvula Nonhlanhla Nene Bagrey Ngwira Mary Nsereko Brenda Okwera Martin O. C. Ota Adam Penn‐Nicholson Nelita du Plessis Srinivasan Ramachandran Ida Rosenkrands Jerry Sadoff Jacky Saul Gary K. Schoolnik Felanji Simukonda Donata Sizemore Steven G. Smith Anne Ben Smith Gian van der Spuy Kim Stanley David L. Tabb Mesfin Tafesse Belete Tegbaru Toyin Togun Gerard Tromp

New biomarkers of tuberculosis (TB) risk and disease are critical for the urgently needed control ongoing TB pandemic. In a prospective multisite study across Subsaharan Africa, we analyzed metabolic profiles in serum plasma from HIV-negative, TB-exposed individuals who either progressed to 3-24 months post-exposure (progressors) or remained healthy (controls). We generated trans-African biosignature TB, which identifies future progressors both on blinded test samples external data sets...

10.1038/s41467-018-07635-7 article EN cc-by Nature Communications 2018-11-30

Novel oral poliovirus vaccine type 2 (nOPV2) has been engineered to improve the genetic stability of Sabin (OPV) and reduce emergence circulating vaccine-derived polioviruses. This trial aimed provide key safety immunogenicity data required for nOPV2 licensure WHO prequalification.

10.1016/s0140-6736(23)02844-1 article EN cc-by The Lancet 2024-02-22

The purified protein derivative (PPD) skin test for Mycobacterium tuberculosis infection lacks specificity. We assessed 2 more specific M. antigens (ESAT-6 and CFP-10) by enzyme-linked immunospot assay (ELISPOT) compared with PPD ELISPOT in Gambia. Of 735 household contacts of 130 sputum smear-positive cases, 476 (65%) tested positive ELISPOT, 300 (41%) test, 218 (30%) ESAT-6/CFP-10 ELISPOT. Only 15 (2%) had results negative With increasing exposure, the percentage subjects who were...

10.1086/382362 article EN Clinical Infectious Diseases 2004-03-22

Few studies have investigated the risk factors for tuberculosis (TB) infection in highly endemic countries. We conducted a household study The Gambia, which tuberculin skin test (TST) was performed members of households 315 smear-positive pulmonary TB cases and 305 community control subjects. being TST positive (10 mm or more) higher contacts than It increased with age, male sex, duration stay but not associated presence bacille de Calmette-Guérin scar. Within cases, positivity males social...

10.1164/rccm.200212-1483oc article EN American Journal of Respiratory and Critical Care Medicine 2003-06-04

Background Studies of Tuberculosis (TB) case contacts are increasingly being utilised for understanding the relationship between M. tuberculosis and human host assessing new interventions diagnostic tests. We aimed to identify incidence rate TB cases among relate this their initial Mantoux ELISPOT test results. Methods Findings After tests exclusion co-prevalent cases, we followed 2348 household sputum smear positive cases. visited them at 3 months, 6 12 18 months 24 investigated those with...

10.1371/journal.pone.0001379 article EN cc-by PLoS ONE 2008-01-02

New tools are required to improve tuberculosis (TB) diagnosis and treatment, including enhanced ability compare new treatment strategies. The ELISPOT assay uses Mycobacterium tuberculosis-specific antigens produce a precise quantitative readout of the immune response pathogen. We hypothesized that TB patients in Gambia would have reduced counts after successful treatment.We recruited Gambian adults with sputum smear culture positive for HIV test, followed them up one year later repeat...

10.1186/1471-2334-6-66 article EN cc-by BMC Infectious Diseases 2006-03-30

Few studies on bacteraemia in Africa have been published. We aimed to prospectively identify the causative organisms of The Gambia and their relation clinical diagnoses, outcome antimicrobial susceptibility. Between November 2003 February 2005 we studied those admitted Medical Research Council hospital who were suspected having bacteraemia. documented features, outcome, pathogens identified susceptibility patterns, searched for factors associated with 871 patients had a blood culture taken....

10.1186/1471-2334-7-2 article EN cc-by BMC Infectious Diseases 2007-01-26

The tuberculosis (TB) epidemic in Africa is on the rise, even low-HIV prevalence settings. Few studies have attempted to identify possible reasons for this. We aimed risk factors pulmonary those attending a general outpatients clinic Gambia, sub-Saharan African country with relatively low HIV community and TB patients. conducted case control study at Medical Research Council Outpatients' Gambia. Pulmonary cases were least 15 years old, controls age sex matched attendees. Participants...

10.1186/1471-2458-6-156 article EN cc-by BMC Public Health 2006-06-19

OBJECTIVE. To compare the enzyme-linked immunospot (ELISPOT) assay with tuberculin skin test (TST) in children for diagnosis of Mycobacterium tuberculosis infection Gambia. METHODS. We divided child contacts sputum smear-positive cases into 3 age categories (<5, 5–9, and 10–14 years) assessed agreement between 2 tests plus their relationship to prior Bacille Calmette-Guerin (BCG) vaccination. categorized a child's level M exposure according where he/she slept relative case: same room,...

10.1542/peds.2005-2095 article EN PEDIATRICS 2006-05-01

Background. Anemia is common in tuberculosis, and multiple etiologies necessitate targeted interventions. The proportion of iron-responsive anemia due to iron deficiency compared with iron-unresponsive impaired absorption/redistribution from tuberculosis-associated immune activation or inflammation unknown. This impedes selection safe effective treatment appropriate intervention timing. Methods. Baseline hemoglobin, ferritin, hepcidin, soluble transferrin receptor (sTfR), were measured 45...

10.1093/cid/ciu945 article EN Clinical Infectious Diseases 2014-11-26

Objective. Tuberculosis (TB) infection is highly prevalent in developing countries. As infected children represent a large proportion of the pool from which TB cases will arise, knowledge factors that influence are importance to evaluate transmission community and adapt control activities. There limited data on risk child populations Methods. We performed household contact study The Gambia (West Africa), who were living with individuals had proven smear-positive pulmonary investigated. A...

10.1542/peds.111.5.e608 article EN PEDIATRICS 2003-05-01

IFN-γ Release Assays (IGRAs) have been licensed for the diagnosis of latent Mycobacterium tuberculosis infection (LTBI). Their performance may depend on assay format and vary across populations settings. We compared diagnostic an in-house T -cell commercial whole blood-based IGRAs LTBI TB disease in The Gambia. Newly diagnosed sputum smear positive cases their household contacts were recruited. Cases bled IGRA had a Mantoux skin test. assessed agreement discordance between tests categorized...

10.1186/1471-2334-7-122 article EN cc-by BMC Infectious Diseases 2007-10-25

BackgroundTuberculosis (TB) remains a global health threat with 9 million new cases and 1.4 deaths per year. In order to develop protective vaccine, we need define the antigens expressed by Mycobacterium tuberculosis (Mtb), which are relevant immunity in high-endemic areas. MethodsWe analysed responses 23 Mtb total of 1247 subjects different HIV TB status across 5 geographically diverse sites Africa (South Africa, The Gambia, Ethiopia, Malawi Uganda). We used 7-day whole blood assay followed...

10.1371/journal.pone.0074080 article EN cc-by PLoS ONE 2013-09-10

Tuberculosis (TB) is still a global health concern, especially in resource-poor countries such as The Gambia. Defining protective immunity to TB challenging: its pathogenesis complex and involves several cellular components of the immune system. Recent works vaccine development suggest important roles innate natural protection TB, including killer (NK) cells. NK cells mediate cytotoxicity cytokine signalling response Mycobacterium tuberculosis (Mtb). can display specific memory-type markers...

10.3389/fimmu.2018.00257 article EN cc-by Frontiers in Immunology 2018-02-19

We investigated host-derived biomarkers that were previously identified in QuantiFERON supernatants, a large pan-African study. recruited individuals presenting with symptoms of pulmonary TB at seven peripheral healthcare facilities six African countries, prior to assessment for disease. then evaluated the concentrations 12 stored supernatants using Luminex platform. Based on laboratory, clinical and radiological findings pre-established algorithm, participants classified as disease or other...

10.1038/s41598-018-20855-7 article EN cc-by Scientific Reports 2018-02-02

Tuberculosis (TB), caused by the Mycobacterium tuberculosis complex (MTBC), remains a pressing global health challenge, with West African region, including The Gambia, experiencing substantial burden. This study explores genetic diversity of MTBC strains circulating in Gambia for nearly two decades (2002-2021) to enhance understanding drug resistance dynamics and inform targeted diagnostic treatment strategies. Using whole-genome sequencing (WGS) data from 1,803 TB isolates, we identified...

10.21203/rs.3.rs-5913893/v1 preprint EN cc-by Research Square (Research Square) 2025-02-27
Coming Soon ...